Enfusion Overview
Enfusion (ENFN) has a P/E ratio of 572.34, above the Technology sector average of 25.38.
Get informed when a big investor buys or sells
+ Follow572.34
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for ENFN is 572.34. That is above the Technology sector average of 25.38. Investors often review this figure alongside Enfusion's historical trend and sector peers before judging valuation or financial health.
Against Technology companies, ENFN currently prints 572.34 for P/E ratio, while the sector average sits near 25.38. That is roughly 2155.5% above the sector mean. Large gaps often invite a closer look at Enfusion's growth, margins, and balance sheet.
A P/E ratio of 572.34 for Enfusion is not 'good' or 'bad' on its own. Compare it with the peer average (25.38) and with ENFN's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting ENFN's P/E ratio (572.34), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Enfusion's P/E ratio against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.
